Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek, email him directly: email@example.com (mailto:firstname.lastname@example.org)
Developer of an equity switching strategy (STORMM) that uses unique momentum indicators to generate buy and sell signals. Daily comments at: http://hgpolites3.wordpress.com/
Not a professional or licensed trader just managing my own portfolio.
bio-seeker...of the next biotech breakthrough. Emerging small cap biotech, cancer immunotherapy, PD-1, CD47, RNAi, CAR-T, KIR/NK.
Investing decisions based on information derived from credible sources...clinical trial data, research papers and independent analysis by those who are qualified to analyze... always skeptical of sell side analysis. Never invest based on a single SA article. Always consider the bio of SA authors... 95% can be ignored altogether based on lack of expertise.